The NeuroErgonomics Lab received funding from NSF on developing and evaluating iPAL (Intelligent Pervasive Augmented reaLity therapy) for Opioid Use Disorder and Recovery. This project will develop intelligent Pervasive Augmented reaLity therapies (iPAL) – a technology-enabled OUD intervention that aims to help OUD sufferers manage their cravings to reduce their risk for relapse or overdose. iPAL integrates complementary psychotherapies (cognitive behavioral therapy and heart rate variability biofeedback) with immersive technologies (augmented and mixed reality) that will offer convenience, discretion in use, in the moment/real-time through personalized strategies. This work is poised to revolutionize how individuals learn, discover, create, and heal in the broader context of developing treatment strategies for those with OUD.